The future of the stent market looks promising with opportunities in the segments of hospital and ambulatory surgical centers. The global stent market is expected to decline in 2020 due to global economic recession led by COVID-19. However, market will witness recovery in the year 2021 and it is expected to reach an estimated $12.5 billion by 2025 with a CAGR of 4% to 6% from 2020 to 2025 .The major growth drivers for this market are increasing interventional cardiology and peripheral vascular procedures and rising adoption of technological advancements in an effort to reduce treatment duration for high risk conventional surgical patients.

Emerging trends which have a direct impact on the dynamics of the stent market include increasing use of bioreabsorbable stent, increasing adoption of co-polymers as raw materials, and increasing adoption of bifurcated stents.

A total of 118 figures / charts and 77 tables are provided in this 188 -page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of stent market report download the report brochure.



Stent opportunities have evolved through number of stages as presented in figure below:

Evolution of Stent Opportunities

In this market, coronary stent is the largest product segment, whereas polymer is the largest in material. Growth in various segments of the stent market are given below:

Stent Market by Segments
The study includes the stent market size and forecast for the stent market through 2025, segmented by product type, material, technology, end use, and region, as follows:

Stents Market by Product Type [Value ($ Million) and Volume (Million Units) from 2014 to 2025]:

  • Coronary Stents
  • Peripheral Vascular Stents


Stents Market by Material [Value ($ Million) and Volume (Million Units) from 2014 to 2025]:

  • Metal
  • Polymer


Stents Market by Technology [Value ($ Million) and Volume (Million Units) from 2014 to 2025]:

  • Bare Metal Stents
  • Drug Eluting Stents
  • Bioreabsorbable Stents


Stents Market by End Use [Value ($ Million)]:

  • Hospital
  • Ambulatory Surgical Center


Stents Market by Region [Value ($ Million) and Volume (Million Units) from 2014 to 2025]:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • APAC
  • China
  • India
  • Japan
  • ROW
  • Brazil


Some of the stents companies profiled in this report include Abbott Laboratory, Boston Scientific, Medtronic public limited company, C R Bard, Cook Medical Inc., Terumo Corporation, and Cardinal Health Inc. and others.

On the basis of comprehensive research, Lucintel forecasts that the coronary stent segment will show above average growth during the forecast period due to increasing cases of cardiovascular disorders.

Within the stent market, the drug eluting stent segment will remain the largest market by technology during the forecast period due to low restenosis rate after surgery. Bioreabsorbable stent is expected to witness the highest growth during the forecast period due to its property of getting absorbed in the body.

North America is expected to remain the largest market during the forecast period mainly due to its well-developed healthcare infrastructure and continued technological advancements across the healthcare industry.

Some of the features of this report:
________________________________________

  • Market size estimates: Stent market size estimation in terms of value ($M) and volume (Million Units) shipment.
  • Trend and forecast analysis: Market trend (2014-2019) and forecast (2020-2025) by end use and use industry.
  • Segmentation analysis: Stent market size by product type, material, technology, end use type in terms of value and volume shipment.
  • Regional analysis: Stent market breakdown by key regions such as North America, Europe, and Asia & Rest of World.
  • Growth opportunities: Analysis on growth opportunities in different applications and regions of stent in the stent market.
  • Strategic analysis: This includes M&A, new product development, and competitive landscape of stent in the stent market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.


This report addresses the following key questions:

Q.1. What are some of the most promising, high-growth opportunities for the stent market by product type (coronary stent and peripheral vascular stent), material (metal and polymer), technology (bare metal stent, drug eluting stent, and bioreabsorbable stent), end use (hospital and ambulatory surgical center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which product segment will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in this stent (coronary stent market, stents market, vascular stents market, cardiac stents market) market?
Q.5. What are the business risks and competitive threats in this stent (coronary stent market, stents market, vascular stents market, cardiac stents market) market?
Q.6. What are the emerging trends in this stent (coronary stent market, stents market, vascular stents market, cardiac stents market) market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the stent (coronary stent market, stents market, vascular stents market, cardiac stents market) market?
Q.8. What are the new developments in the stent (coronary stent market, stents market, vascular stents market, cardiac stents market) market and which companies are leading these developments?
Q.9. Who are the major players in this stent (coronary stent market, stents market, vascular stents market, cardiac stents market) market? What strategic initiatives are being taken by key companies for business growth?
Q.10. What are some of the competing products in this stent (coronary stent market, stents market, vascular stents market, cardiac stents market) market and how big of a threat do they pose for loss of market share by product substitution?
Q.11. What M&A activity has occurred in the last 5 years in this stent (coronary stent market, stents market, vascular stents market, cardiac stents market) market?


Report scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages 188
Market Representation / Units Revenue in US $ Billion and Volume in Million Units
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger Acquisitions & Joint Venture, and Company Profiling
Market Segments By product type (coronary stent and peripheral vascular stent), By material (metal and polymer), By technology (bare metal stent, drug eluting stent, and bioreabsorbable stent), and By end use (hospital and ambulatory surgical center)
Regional Scope North America (The United States, Mexico, and Canada), Europe (Germany, France, United Kingdom, Italy, and Spain), Asia Pacific (China, India, and Japan), and RoW (Brazil)
Customization 10% Customization Without any Additional Cost